James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 162 shares at $78.03 ($13K) on 2024-08-29, disclosed to the SEC on 2024-08-30.
Open-market sale of $13k MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRNA | SELL | 2024-10-08 | $43K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |
| MRNA | SELL | 2024-07-09 | $163K | — | Filing → |